Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannu Aro

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Duodecim; Laaketieteellinen Aikakauskirja|April 6, 2004
[Growth factors in the treatment of bone deficiencies and bone diseases]Kristiina Heikinheimo, Anne Kokkari, Tia Turunen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 22, 2010
Expression of ezrin, Bcl-2, and Ki-67 in chondrosarcomasMirva Söderström, Tuire Palokangas, Tero Vahlberg, et al.
Scandinavian Journal of Pain|June 20, 2018
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioidsHarald Breivik, Tone Marte Ljosaa, Kristian Stengaard-Pedersen, et al.
Scandinavian Journal of Pain|June 20, 2018
Corrigendum to "A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of 7 day buprenorphine transdermal patch in osteoarthritis patients naïve to potent-opioids" [Scandinavian Journal of Pain 1 (2010) 122-141]Harald Breivik, Tone Marte Ljosaa, Kristian Stengaard-Pedersen, et al.
Nuclear Medicine and Biology|February 15, 2011
PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremitiesPaula Lindholm, Eija Sutinen, Vesa Oikonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|September 4, 2007
[Not Available]Matti Välimäki, Esko Alhava, Hannu Aro, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Duodecim; Laaketieteellinen Aikakauskirja|April 6, 2004
[Growth factors in the treatment of bone deficiencies and bone diseases]Kristiina Heikinheimo, Anne Kokkari, Tia Turunen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|September 22, 2010
Expression of ezrin, Bcl-2, and Ki-67 in chondrosarcomasMirva Söderström, Tuire Palokangas, Tero Vahlberg, et al.
Scandinavian Journal of Pain|June 20, 2018
A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioidsHarald Breivik, Tone Marte Ljosaa, Kristian Stengaard-Pedersen, et al.
Scandinavian Journal of Pain|June 20, 2018
Corrigendum to "A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of 7 day buprenorphine transdermal patch in osteoarthritis patients naïve to potent-opioids" [Scandinavian Journal of Pain 1 (2010) 122-141]Harald Breivik, Tone Marte Ljosaa, Kristian Stengaard-Pedersen, et al.
Nuclear Medicine and Biology|February 15, 2011
PET imaging of blood flow and glucose metabolism in localized musculoskeletal tumors of the extremitiesPaula Lindholm, Eija Sutinen, Vesa Oikonen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|September 4, 2007
[Not Available]Matti Välimäki, Esko Alhava, Hannu Aro, et al.
The Journal of Bone and Joint Surgery. American Volume|December 11, 2002
Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patientsShunmugam Govender, Cristina Csimma, Harry K Genant, et al.
Pageof 1